News
BMXMF
115.00
NaN%
--
Weekly Report: what happened at BMXMF last week (0330-0403)?
Weekly Report · 10h ago
Weekly Report: what happened at BMXMF last week (0323-0327)?
Weekly Report · 03/30 09:30
Weekly Report: what happened at BMXMF last week (0316-0320)?
Weekly Report · 03/23 09:29
Weekly Report: what happened at BMXMF last week (0309-0313)?
Weekly Report · 03/16 09:29
UBS Sticks to Their Buy Rating for bioMerieux (0RUG)
TipRanks · 03/11 10:05
Weekly Report: what happened at BMXMF last week (0302-0306)?
Weekly Report · 03/09 09:29
Weekly Report: what happened at BMXMF last week (0223-0227)?
Weekly Report · 03/02 09:29
bioMerieux price target lowered to EUR 100 from EUR 110 at Barclays
TipRanks · 02/24 17:05
Weekly Report: what happened at BMXMF last week (0216-0220)?
Weekly Report · 02/23 09:29
Weekly Report: what happened at BMXMF last week (0209-0213)?
Weekly Report · 02/16 09:29
Weekly Report: what happened at BMXMF last week (0202-0206)?
Weekly Report · 02/09 09:30
Morgan Stanley Remains a Hold on bioMerieux (0RUG)
TipRanks · 02/02 17:07
Weekly Report: what happened at BMXMF last week (0126-0130)?
Weekly Report · 02/02 09:29
bioMerieux downgraded to Neutral from Outperform at BNP Paribas
TipRanks · 01/28 14:55
Weekly Report: what happened at BMXMF last week (0119-0123)?
Weekly Report · 01/26 09:29
RBC Capital Reaffirms Their Hold Rating on bioMerieux (0RUG)
TipRanks · 01/23 16:36
Weekly Report: what happened at BMXMF last week (0112-0116)?
Weekly Report · 01/19 09:32
Weekly Report: what happened at BMXMF last week (0105-0109)?
Weekly Report · 01/12 09:31
Barclays downgrades bioMerieux (0RUG) to a Hold
TipRanks · 01/08 01:26
Weekly Report: what happened at BMXMF last week (1229-0102)?
Weekly Report · 01/05 09:29
More
Webull provides a variety of real-time BMXMF stock news. You can receive the latest news about Biomerieux through multiple platforms. This information may help you make smarter investment decisions.
About BMXMF
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.